 NASHVILLE, Tenn., April 14, 2021 GLOBE NEWSWIRE -- Harrow Health, Inc. NASDAQ: HROW, an ophthalmic-focused healthcare company, today announced certain preliminary unaudited financial results for the first quarter ended March 31, 2021. 